Torsdag 29 Maj | 07:47:44 Europe / Stockholm

Prenumeration

2023-05-22 07:58:00

Redeye notes an increasing OPEX well above our expectations, with sales coming in lower than estimated and a pressed cash position that needs to be sorted quickly. We adjust our fair value range according to the latest share price developments (which impact our equity issue assumptions).

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/